SCHEMBL2381772

SCHEMBL2381772

CCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)O)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.61
PLA2G5 P39877 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.55
PSMB5 P28074 2/20 0.55
FAAH O00519 10/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPK1 P28482 1/20 0.51
EPHX2 P34913 3/20 0.47
NOD1 Q9Y239 1/20 0.47
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30165156 0.90 PSMB5 (0.57) PLA2G2APLA2G5PSMB5FAAHMEN1
SCHEMBL9666963 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL7773487 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL15649018 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL9666571 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL25192254 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL543200 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL9666565 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL15697666 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1
SCHEMBL9666953 0.89 PLA2G2A (0.71) PLA2G2APLA2G5SMN1; SMN2FAAHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2756067-B1 MICROCAPSULE COMPOSITIONS COMPRISING PH TUNEABLE DI-AMIDO GELLANTS PROCTER & GAMBLE (US) 2017-06-14 EP claimed
EP-2365052-B1 pH tuneable-gellant for use in consumer product compositions PROCTER & GAMBLE (US) 2016-07-13 EP claimed
EP-2365053-B1 Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making PROCTER & GAMBLE (US) 2016-04-27 EP claimed
US-9271912-B2 Personal care compositions comprising a pH tuneable gellant and methods of using THE PROCTER & GAMBLE COMPANY (US) 2016-03-01 US claimed
US-20130336903-A1 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using THE PROCTER & GAMBLE COMPANY 2013-12-19 US claimed
US-20130303427-A1 MICROCAPSULE COMPOSITIONS COMPRISING pH TUNEABLE DI-AMIDO GELLANTS THE PROCTER & GAMBLE COMPANY 2013-11-14 US claimed
EP-2365053-A9 Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making The Procter & Gamble Company (US) 2013-05-15 EP claimed
US-20110224124-A1 pH Tuneable Amido-Gellant For Use In Consumer Product Compositions THE PROCTER & GAMBLE COMPANY 2011-09-15 US claimed
US-20110220537-A1 Liquid Detergent Compositions Comprising pH Tuneable Amido-Gellants, and Processes For Making THE PROCTER & GAMBLE COMPANY 2011-09-15 US claimed
EP-2365052-A1 pH tuneable-gellant for use in consumer product compositions The Procter & Gamble Company (US) 2011-09-14 EP claimed
EP-2365053-A1 Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making The Procter & Gamble Company (US) 2011-09-14 EP claimed
EP-2365052-B1 pH tuneable-gellant for use in consumer product compositions PROCTER & GAMBLE (US) 2016-07-13 EP disclosed
EP-2365052-B1 pH tuneable-gellant for use in consumer product compositions PROCTER & GAMBLE (US) 2016-07-13 EP disclosed
EP-2365053-B1 Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making PROCTER & GAMBLE (US) 2016-04-27 EP disclosed
EP-2365053-B1 Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making PROCTER & GAMBLE (US) 2016-04-27 EP disclosed
WO-2011112910-A1 LIQUID DETERGENT COMPOSITIONS COMPRISING PH TUNEABLE AMIDO-GELLANTS, AND PROCESSES FOR MAKING THE PROCTER & GAMBLE COMPANY (US) 2011-09-15 WO disclosed
US-20110224124-A1 pH Tuneable Amido-Gellant For Use In Consumer Product Compositions THE PROCTER & GAMBLE COMPANY 2011-09-15 US disclosed
EP-2365052-A1 pH tuneable-gellant for use in consumer product compositions The Procter & Gamble Company (US) 2011-09-14 EP disclosed
EP-2365053-A1 Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making The Procter & Gamble Company (US) 2011-09-14 EP disclosed
EP-2365052-A1 pH tuneable-gellant for use in consumer product compositions The Procter & Gamble Company (US) 2011-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130336903-A1 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using ARGLU1, F12, GALR1 PLA2G2A 1367/4885PLA2G5 314/4885SMN1; SMN2 2669/4885
US-20110224124-A1 pH Tuneable Amido-Gellant For Use In Consumer Product Compositions AGPAT2, AGPAT5, GNAO1 PLA2G2A 245/4885PLA2G5 163/4885SMN1; SMN2 2091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.